Skip to main content
TipRanks
Go Ultimate75% OFF

Latigo Biotherapeutics, Inc. (LTGO) Income Statement

39 Followers

Latigo Biotherapeutics, Inc. Income Statement

Last quarter (Q3 2026), Latigo Biotherapeutics, Inc.'s total revenue was $0.00. In Q3, Latigo Biotherapeutics, Inc.'s net income was $-20.95M. See Latigo Biotherapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25
$ 0.00
$ 0.00
$ 110.39M
Depreciation and Amortization$ 249.00K
$ -110.14M
$ -110.39M
$ 1.23M
$ -109.17M
$ -109.17M
Per Share Metrics
Basic EPS$ -2.48
Diluted EPS$ -2.48
Weighted Average Shares Outstanding43.96M
Weighted Average Shares Outstanding (Diluted)43.96M

Currency in USD

Latigo Biotherapeutics, Inc. Earnings and Revenue History

-120M-80M-40M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2025RevenueEarningsProfit Margin